article thumbnail

AeroVironment Completes $405M Arcturus UAV Acquisition

socalTECH

Simi Valley-based Aerovironment said yesterday that it has completed the $405M acquisition of Arcturus UAV, a designer and manufacturer of high performance, unmanned aircraft systems (UAS). The deal had originally been announced on January 13th.

Arcturus 124
article thumbnail

AeroVironment Acquires Arcturus UAV For $405M

socalTECH

Simi Valley-based unmanned aerial vehicle maker Aerovironment says it is acquiring Arcturus UAV, a developer of unmanned aircraft used by the military, in a deal worth $405M in cash and stock. AeroVironment said it would pay $355M in cash and $50M in stock for Arcturus, which is based in Petaluma, Claifornia.

Arcturus 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Arcturus Gets $11M For 3D Video Editing Tools

socalTECH

Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games. The startup is led by CEO Kamal Mistry.

Arcturus 100
article thumbnail

Arcturus Therapeutics Gets $3M From Cystic Fibrosis Foundation

socalTECH

San Diego-based Arcturus Therapeutics , a developer of mRNA-based treatments for disease, has signed a deal to receive up to $3M in funding from the Cystic Fibrosis Foundation Therapeutics, a nonprofit which supports drug discovery and development. READ MORE>>.

Arcturus 167
article thumbnail

Arcturus Therapeutics Gets $220M More In Support For Vaccine Efforts

socalTECH

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds.

Arcturus 113
article thumbnail

Arcturus Therapeutics Gets $1.3M

socalTECH

San Diego-based Arcturus Therapeutics , which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M Arcturus Therapeutics is headed by Joseph E. Arcturus Therapeutics is headed by Joseph E. arcturus therapeutics venture capital rnai lifescience biotech' in a seed fudning round.

Arcturus 138
article thumbnail

Arcturus Poised to Move Liver Drug, COVID-19 Vaccine Into Clinic

Xconomy

Messenger RNA drug developer Arcturus Therapeutics is ready to kick off its first-ever human trials this year, beginning clinical evaluation of its lead drug candidate and testing a vaccine designed to target the novel coronavirus. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Arcturus 117